Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include.
Content type: Research article. Breast cancer remains as one of the most lethal types of cancer in women. Among various subtypes, triple-negative breast cancer TNBC is the most aggressive and hard to treat type of breast cancer.
Due to migration of article submission systems, please check the status of your submitted manuscript in the relevant system below:. Once production of your article has started, you can track the status of your article via Track Your Accepted Article. Search in:.
Breast cancerdisease characterized by the growth of malignant cells in the mammary glands. Breast cancer can strike males and femalesalthough women are about times more likely to develop the disease than men. Most cancers in female breasts form shortly before, during, or after menopausewith three-quarters of all cases being diagnosed after age
Thank you for visiting nature. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer.
Breast cancer is the second leading cause of cancer deaths among women. The development of breast cancer is a multi-step process involving multiple cell types, and its prevention remains challenging in the world. Early diagnosis of breast cancer is one of the best approaches to prevent this disease.
FDA has expanded the approved use of the drug ado-trastuzumab emtansine Kadcylaalso called T-DM1, to include adjuvant treatment in some women with early-stage HER2-positive breast cancer. Many women diagnosed with ovarian and breast cancer are not undergoing tests for inherited genetic mutations that can provide important information to help guide decisions about treatment and longer-term cancer screening, a new study has found. FDA has approved atezolizumab Tecentriq in combination with chemotherapy for the treatment of some women with advanced triple-negative breast cancer.
The official journal of the Japanese Breast Cancer Society, Breast Cancer publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research. It develops a new focus and new perspectives for all who are concerned with breast cancer. Breast Cancer presents original articles describing clinical, epidemiological studies and laboratory investigations regarding breast cancer and related diseases.
Breast cancer is cancer that develops from breast tissue. Risk factors for developing breast cancer include being female, obesitylack of physical exercise, drinking alcoholhormone replacement therapy during menopauseionizing radiationearly age at first menstruationhaving children late or not at all, older age, prior history of breast cancer, and family history. The balance of benefits versus harms of breast cancer screening is controversial. A Cochrane review stated that it is unclear if mammographic screening does more good or harm.